From behind the ocean … a “strong” blow to AstraZeneca after the torrent of reassurances


The National Institute of Allergy and Infectious Diseases said in a statement, “It is concerned that AstraZeneca may have used outdated information in these trials, which has led to an incomplete view of the effectiveness of the vaccine.”

“We are urging the company to work with the Data and Safety Control Board to evaluate the effectiveness of the data, and to ensure that the most accurate, up-to-date and effective data will be published as soon as possible,” he added, according to AFP.

It was a laboratory AstraZeneca Monday, he defended his vaccine, which a large part of Europeans refuse to receive, stressing that it is 80% effective against Corona virus in elderly people, and does not increase the risk of blood clots, after clinical trials conducted in the United States that included 32,449 people.

The AstraZeneca lab said it was 79 percent effective at preventing GHF Covid cases It shows symptoms in the general population, while its effectiveness is 100% in terms of preventing infection with a dangerous degree of disease and the progression of the condition to the point that the patient is hospitalized.

Several countries suspended its use earlier this month, citing concerns that it could cause strokes, which in some cases could be fatal.

And Thursday, she considered European Medicines Agency Thursday that it was “safe and effective” and its use resumed in several countries.

Source link


Please enter your comment!
Please enter your name here